Identification of genetic factors that predispose to either immune checkpoint inhibitor or conventional chemotherapy toxicity

Palles, Claire (Principal Investigator)
Middleton, Gary (Co-Investigator)
Steven, Neil (Co-Investigator)

Short title	Identification of genetic factors that predispose to either immune checkpoint inhibitor or conventional chemotherapy toxicity
Status	Active
Effective start/end date	1/09/19 → 31/12/24

Funding

Cancer Research Uk

2 Article

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
Payne, K., Brooks, J., Batis, N., Khan, N., El-Asrag, M., Nankivell, P., Mehanna, H. & Taylor, G., 9 Nov 2023, In: British Journal of Cancer. 129, 10, p. 1590-1598 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
29 Downloads (Pure)
Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity
Chin, I. S., Khan, A., Olsson-Brown, A., Papa, S., Middleton, G. & Palles, C., 24 Dec 2022, In: NPJ Genomic Medicine. 7, 1, 14 p., 73.
Research output: Contribution to journal › Article › peer-review

Open Access
File
40 Downloads (Pure)